Single-electron reduction of a carbonyl to a ketyl enables access to a polarity-reversed platform of reactivity for this cornerstone functional group. However, the synthetic utility of the ketyl radical is hindered by the strong reductants necessary for its generation, which also limit its reactivity to net reductive mechanisms. Herein, we report a strategy for net redox-neutral generation and reaction of ketyl radicals. The in situ conversion of aldehydes to α-acetoxy iodides lowers their reduction potential (Δ 1200 mV), allowing for milder access to the corresponding ketyl radicals and an oxidative termination event. Upon subjecting these iodides to a Mn2(CO)10 pre-catalyst and visible light irradiation, an atom transfer radical addition (ATRA) mechanism affords a broad scope of vinyl iodide products with high Z-selectivity.
A cross-selective
aza-pinacol coupling of aldehydes and imines
has been developed to afford valuable β-amino alcohols. This
strategy enables chemoselective conversion of aliphatic aldehydes
to ketyl radicals, in the presence of more easily reduced imines and
other functional groups. Upon carbonyl-specific activation by AcI,
a photoinitiated Mn catalyst selectively reduces the resulting α-oxy
iodide by an atom transfer mechanism. The ensuing ketyl radical selectively
couples to imines, precluding homodimerization by a classical reductive
approach. In this first example of reductive, ketyl coupling by atom
transfer catalysis, Zn serves as a terminal reductant to facilitate
Mn catalyst turnover. This new strategy also enables ketyl radical
couplings to alkenes, alkynes, aldehydes, propellanes, and chiral
imines.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.